Skip to Main Content

Paper Details

LUNAR: a randomized Phase 2 study of <sup>177</sup> Lutetium-PSMA Neoadjuvant to Ablative Radiotherapy for Oligorecurrent Prostate Cancer (clinical trial protocol).
BJU Int
4
2023
Author NameAffiliation
Ting Martin MaUniversity of California los angeles
Johannes CzerninUniversity of California los angeles
Johannes CzerninDavid Geffen School of Medicine, University of California los angeles
Luca F ValleUniversity of California los angeles
Michael L SteinbergUniversity of California los angeles
Magnus DahlbomUniversity of California los angeles
Magnus DahlbomDavid Geffen School of Medicine, University of California los angeles
Robert E ReiterUniversity of California los angeles
Matthew B RettigDavid Geffen School of Medicine, University of California los angeles
Minsong CaoUniversity of California los angeles
Jeremie CalaisUniversity of California los angeles
Jeremie CalaisDavid Geffen School of Medicine, University of California los angeles
Amar U KishanUniversity of California los angeles
Amar U KishanUniversity of California los angeles
  • 1 - 14

Datasets

Release 1.2